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Production and metabolic clearance of calcitriol in acute renal failure.
Metabolic clearance rate (MCR) and production rate (PR) of calcitriol
were studied three and seven days after ischemic acute tubular necrosis
(ATN). Creatinine clearance was decreased three days after clamping
the renal arteries (0.42 0.03 mlIminJlOO g, N = 6 in ATN vs. 0.68
0.09, N = 7 in sham controls; P < 0.001). Plasma concentrations (24.1
1.9 pg/mI) and PR of calcitriol (9.8 0.91 ng/kg/day) were signifi-
cantly lower in ATN rats three days after ischemic insult when
compared to sham control rats, respectively (76.6 7.3 pg/mI, and 29.6
3.3 ng/kg/day; both P < 0.01). The MCRs of calcitriol were not
different between ATN (0.28 0.02 mI/mm/kg) and sham control rats
(0.27 0.01) By the seventh day after ischemic injury, when creatinine
clearance of ATN rats returned to normal, both the PR and plasma
concentrations of calcitriol also returned to normal values in these
animals. In order to assess the effect of uremia on calcitriol metabolism,
MCR and PR of calcitriol were measured in rats with reinfusion of their
urines for 24 hours. The PR of calcitriol was significantly decreased
(9.42 1.21; vs. controls, 20.5 2.9 ng/kglday, P < 0.001) in uremic
animals. Since decreased PR of calcitriol was also accompanied by
decreased MCR of calcitriol, plasma concentrations of calcitriol of the
uremic rats with intact kidneys remained within normal values. We
conclude that the PR of calcitriol is decreased early in ATN rats.
Although the MCR was not decreased in mild ATN rats, it may
decrease in severe acute renal failure.
Calcitriol is synthesized in the kidney by conversion of
25-hydroxyvitamin D3 by the enzyme lcs-hydroxylase [1]. 1cr-
hydroxylase is localized in the mitochondria of proximal tu-
bules [21. Therefore, the biosynthesis of calcitriol requires
metabolically normal renal tubule. Although patients with acute
tubular necrosis and severe chronic renal failure are expected to
have decreased plasma concentrations of calcitriol, the synthe-
sis of this active vitamin D metabolite has not been measured in
acute renal failure. Moreover, the effect of uremia on the
metabolic degradation of calcitnol has not been studied in acute
renal failure. We have previously demonstrated that the pro-
duction of calcitriol is decreased in chronic renal failure. The
decreased production is attended by decreased metabolic clear-
ance of calcitriol, suggesting that the degradation of calcitriol by
various tissues in renal failure is also reduced [3]. These
findings indicate that normal calcium homeostasis not only
requires normal plasma concentrations of calcitriol, but may
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also depend on the metabolism of calcitriol by its target organs.
In this experiment, we have utilized the technique of constant
infusion of radiolabelled calcitriol to study the metabolic pro-
duction and clearance of calcitriol in acute renal failure.
Methods
Male Sprague-Dawley rats (160 to 230 g) were fed with Purina
rat chow containing 1.0% calcium and 0.8% phosphorus and tap
water throughout the experiment. Acute tubular necrosis was
achieved by clamping bilateral renal arteries for 40 minutes
through bilateral flank incisions as previously described [4].
Control animals had sham operations. Metabolic clearance of
calcitriol was performed in two groups of animals: one group rt
three days and the other at seven days after the ischemic insult
of the kidney. The radiolabelled calcitriol was infused into
animals on day 2 through day 3, and day 6 through day 7 for 20
hours, respectively, after ischemic injury. MCR of calcitnol
was measured at 18, 19 and 20 hours after the isotope infusion
as described below.
The effect of uremia on metabolic clearance of calcitriol was
also conducted in another group of animals (230 to 260 g) with
normal kidneys. Acute uremia was created in this group of rats
by reinfusion of their urines for 24 hours as we have previously
described [5]. Briefly, this was accomplished by means of an
electronic switching device that was connected to the urine
container by two wire electrodes. Whenever the animal ex-
creted 0.5 ml of urine into the container, the switching device
was triggered to activate a pump that infused 0.5 ml of urine
back into the animal through a femoral venous catheter. Control
animals were infused with saline solution at a rate of 0.005
ml/min/l0O g. The radiolabelled calcitriol was infused into rats
four hours after urine reinfusion or saline infusion. MCR was
measured at 18, 19, and 20 hours after the isotope infusion as
described below.
On the day of experiments, the rats were weighed and
anesthetized with ether. Both femoral artery and femoral vein
were cannulated with polyethylene tubing (PE 50) for blood
sampling and infusion purposes. A PE 50 tube was placed in the
bladder for urine collection. After surgical instrumentation the
animals were placed in individual restraining cages and allowed
to recover from ether anesthesia. All animals were fasted during
the clearance studies. Metabolic clearance rate (MCR) of
calcitriol was measured by constant infusion method [6, 7].
Assuming that infused tracer 3H-calcitriol and endogenous
calcitriol are metabolized identically in vivo, then it follows that
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when the infused tracer 3H-calcitriol achieves a steady-state
plasma concentration after a given period of infusion, the ratio
of the infusion rate of 3H-calcitriol to the steady state concen-
tration of 3H-calcitriol equals the ratio of the rate of calcitriol
synthesis to the endogenous plasma concentration of calcitriol.
Thus production rate (PR) of calcitriol can be calculated as
follows:
PR = Infusion rate of 3H-calcitriol/Mean steady-state plasma
concentration 3H-calcitriol x endogenous plasma concentration
of calcitriol
and metabolic clearance rate of calcitriol (MCR) is defined as:
MCR = Infusion rate of 3H-calcitriol/Mean steady-state plasma
concentration of 3H-calcitriol
Radioactive calcitriol 1 a,25(26,27-3H)(OH)D3, specific activ-
ity 160 Ci/mmol (New England Nuclear, Boston, Massachu-
setts, USA), in ethanol was mixed with 0.5 ml rat plasma and
diluted with a sufficient volume of normal saline to infuse
intravenously at a rate of 0.0025 ml/min/lOO g. Approximately
0.005 pCi/hr of radioactive calcitriol was infused into each
animal for 20 hours. Animals were fasted during the infusion
period. The total amount of radiolabelled calcitriol infused into
each animal was approximately 3% of the estimated daily
endogenous production of calcitriol. Arterial blood, 0.5 ml, was
withdrawn at 18, 19, and 20 hours. The blood was centrifuged
immediately, and plasma was separated and stored at —20°C
until radioactive calcitriol was determined. The red blood cells
were mixed with saline equivalent to the plasma volume taken
and returned to the animals. In our preliminary study, we have
found that less than 1% (N 16) of the infused 3H-calcitriol
tracer was excreted in 24 hours. Therefore, urine reinfusion into
rats does not change the infusion rate of 3H-calcitriol to the
animals in this experiment.
Plasma concentrations of radioactive calcitriol were mea-
sured as follows [8]: Two hundred microliters of thawed plasma
were brought to a volume of 1 ml with normal saline. Cold
calcitriol (500 ng in 50 pi absolute ethanol) was added to
monitor recovery. Plasma protein was precipitated with 1 ml
acetonitrile followed by vigorous vortexing and centrifugation.
The supernatant was combined with 0.5 ml K2HPO4 (0.4 M, pH
10.6) and applied to a 3 ml LC-l8 Supelclean mini-column
(Supelco Inc., Bellefonte, Pennsylvania, USA) that had been
equilibrated in methanol overnight. The column was eluted with
5 ml of double distilled water, 3 ml of 70% methanol and 6 ml of
acetonitrile [81. The final fraction, containing hydroxylated
vitamin D metabolites, was dried under nitrogen. The residue
was dissolved in 500 pi of HPLC solvent containing 88%
hexane, 10% isopropanol and 2% methanol [91 and injected into
a HPLC solvent delivery system (Spectra Physics SP 8710, San
Jose, California, USA) equipped with a 5 s silica analytical
column (Alltech 605 SI, Deerfield, Illinois, USA). Solvent flow
rate was 2 ml/min, and 1 ml fractions were collected concur-
rently with the appearance of the cold calcitriol peak on a 254
nm optical detector (Spectra Physics 8300). Calcitriol recovery
averaged 75%. Collected fractions were mixed with an organic
phase scintillation liquid and counted (Beckman LS 8100 Scin-
tillation Counter, Beckman Instruments, Fullerton, California,
USA). Coefficients of variation for the plasma tracer measure-
ments at 18, 19, and 20 hours averaged less than 7%. The
radioactivity of 3H-calcitriol extracted from plasma by HPLC
ranged from 1300 to 2400 cpm/ml, which is 14% to 31% lower
than the total plasma radioactivity. We have demonstrated that
the straight phase HPLC system separates 1 ,25-dihydroxyvita-
mm D3 from 1,25,26-trihydroxyvitamin D3, calcitroic acid and
1 ,24,25-trihydroxyvitamin D3. Furthermore, the peak of radio-
activity comigrating with calcitriol on straight phase HPLC
eluted as a single radioactive peak that co-eluted with standard
calcitriol on a reverse phase system (20% water in methanol)
using a 5 s C-18 analytical column with excellent recovery (>
90%). The non-radioactive vitamin D metabolites were obtained
from Dr. M. Uskokovic (Roche Institute).
At the end of the MCR study, arterial blood was obtained for
the measurements of pH, pCO2, ionized calcium, total plasma
calcium, phosphorus, creatinine and calcitriol. Creatinine clear-
ance was calculated using the 20 hours urine collection. Plasma
calcitriol was measured in duplicate using radioreceptor assay
kits (Immuno Nuclear Corp., Stillwater, Minnesota, USA)
according to the method described by Reinhardt et al [8].
Analytical methods
Calcium was measured with atomic absorption spectropho-
tometry (Model 306 Perkin Elmer, Norwalk, Connecticut).
Phosphorus was determined by a method described previously
[10]. Ionized calcium was measured by NOVA Model 6 calcium
electrode (NOVA Biomedical, Newton, Massachusetts, USA).
Blood p1-I and pCO2 were measured by IL 713 pH/blood gas
analyzer (Instrumentation Lab Inc., Lexington, Massachusetts,
USA). Creatinine was determined by the Jaffe reaction.
All data are expressed as mean SEM. Statistical analysis
was performed using paired and unpaired Student (-tests wher-
ever appropriate. A value of < 0.05 was considered significant.
Results
Renal function and plasma concentrations of calcium, phos-
phorus and blood gases of animals three days after ischemic
injury are summarized in Table 1. Body weights of sham
controls (224 1.9 g) and animals with acute tubular necrosis
(ATN; 229 5.8 g) were not different before the surgery. Three
days after renal arterial clamping, the animals with ATN lost
weight (216 3.0 g), whereas the weight of animals with sham
operation remained the same (228 3.3 g). The creatinine
clearance of ATN rats was significantly decreased compared to
the controls. Plasma concentrations of calcium and phosphorus
and the values of blood gases were not different between the
two groups of animals.
The production rate of calcitriol and its metabolic clearance
in rats with acute renal failure are presented in Table 2. The
individual MCRs and the mean MCRs of calcitriol of the two
groups of animals at 18, 19, and 20 hours after the infusion of
isotope are depicted in Figure 1. The MCR of each group of
animals achieved a steady state after 18 hours of infusion, since
the mean MCRs measured at the above time intervals were not
different within each group of animals (paired f-test). The
average MCRs of the three time intervals of sham controls and
ATN rats are presented in Table 2. Plasma concentrations of
calcitriol were significantly lower in the ATN animals three
days after the ischemic insult than in the controls. Therefore,
the calculated production rates of calcitriol were also signifi-
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Table 1. Renal function and plasma coneentrations of calcium, phosphorus and blood gases three days after ischemic injury of kidneys
Body wt
g
Sr
mg/di
CCr
ml/min/JOO g
PCa
mg/dl
PCa
mg/d!
P,
mg/dl pH
pCO2
mmHg
Sham
Controls
N= 6
ATN
N = 7
228
216
0.42
0.66
0.68
0,42
10.30
10.26
4.73
4.75
7.05
7.59
7.39
7.39
34.5
34.4
P values <0.02 <0.001 <0.001 NS NS NS NS NS
Abbreviations are: SCr, serum creatinine; Ccr, creatinine clearance; P and PCa+, total plasma calcium and ionized calcium; Ps,, plasma
phosphorus; and ATN, acute tubular necrosis.
cantly lower in ATN rats. MCR, however, was not different
between the two groups of animals. The coefficient of variation
for the measurements of plasma tracer averaged less than 7%,
suggesting that the plasma concentrations of 3H-calcitriol had
reached steady state.
Renal function and plasma concentrations of calcium and
phosphorus as well as blood gases of animals seven days after
the ischemic insult are summarized in Table 3. The mean
plasma concentrations of creatinine five days after clamping the
renal arteries was 0.75 0.03 mgldl. This value was signifi-
cantly higher than that of control sham-operated animals (0.49
.02 mgldl). By the seventh day after ischemic injury, the
plasma concentrations of creatinine and creatinine clearances
had already returned to normal values. Body weight of rats
prior to the surgery were not different between the sham
controls (173 3.5 g) and ATN rats (172 2.4 g). Both groups
of animals had gained weight during the seven days after
surgery, and body weights were not different (Table 3). Plasma
concentrations of calcium and phosphorus and blood gases
were also not different between the two groups of animals.
The production rate and the MCR of calcitriol of rats seven
days after the initial ischemic injury and control rats are
presented in Table 4. The individual as well as the mean MCRs
of calcitriol are depicted in Figure 2. The plasma concentrations
of calcitriol and the production rates of calcitriol of ATN rats
had returned to normal, and were no longer different from those
of the control sham-operated rats.
In order to examine whether severe uremia has any influence
on calcitriol metabolism in an animal with intact kidneys,
another group of animals were made uremic by reinfusion of
their urines for 24 hours, and calcitriol metabolism was studied
near the end of urine reinfusion. Plasma concentrations of
creatinine and phosphorus of urine reinfused rats were signifi-
cantly elevated at the end of urine reinfusion as compared to the
controls. Total plasma concentrations of calcium were lower in
uremic animals; however, plasma concentrations of ionized
calcium were not different between the two groups of animals.
The animals with urine reinfusion became severely acidotic as
the blood pH had decreased to 7.15 (Table 5).
The results of the effect of uremia on calcitriol metabolism in
animals with normal kidneys are summarized in Table 6 and
Figure 3. The plasma concentrations of calcitriol in uremic rats
tended to be lower but were not different from the controls.
Both the production rate and the MCR of calcitriol were
significantly decreased in uremic rats 24 hours after urine
reinfusion.
Table 2. Production and metabolic clearance of calcitriol
after ischemic injury of kidneys
three days
Plasma
calcitriol MCR PR
pg/mi mi/mm/kg ng/kg/day
C.V.
%
Sham
Controls
N= 7
ATH
N = 6
76.6 0.27 29.6
24.1 0.28 9.8
5.13
6.85
P values <u.01 NS <0.01 NS
Abbreviations are: MCR, metabolic clearance rate (the value repre-
sents the average of three determinations performed at 18, 19, and 20
hours after the isotope infusion); PR, production rate; C.V., coefficient
of variation for the plasma tracer measurements at 18, 19, and 20 hours.
Discussion
The kidney is the major organ capable of converting 25-
hydroxyvitamin D3 [25(OH)D31 to caicitriol. Thus, plasma
concentrations of calcitriol are decreased during the oliguric
phase in rhabdomyolysis-induced acute renal failure [11]. In
patients with gram-negative sepsis and acute renal failure,
plasma levels of calcitriol are also reported to be lower [121. In
that report several patients may have developed peripheral
tissue resistance to calcitriol. Calcitriol is the most potent of the
vitamin D metabolites in modulating intestinal absorption of
calcium [1]. Intestinal absorption of calcium is impaired in renal
failure [13—151. Thus decreased calcium absorption in renal
failure could be due to either lower plasma concentrations of
calcitriol or decreased intestinal responsiveness to calcitriol
stimulation. It is, therefore, important to characterize not only
the production of calcitriol but also its metabolic clearance,
since the latter may provide information about the degradation
of calcitriol by its target organs in renal failure.
Acute tubular necrosis occurs following renal ischemia. The
proximal tubular changes include necrosis of tubular epithe-
hum, marked vacuolization of tubule cells, and swelling and
disruption of mitochondria [16]. Since the enzyme la-hydrox-
ylase resides in the mitochondria of proximal tubule [2], it is not
surprising that the synthesis of calcitriol is reduced in animals
with ATN. Although metabolic acidosis [17—191 and retention of
phosphate and hyperphosphatemia [6, 20], which suppress
calcitriol synthesis, may occur in severe acute renal failure,
they were absent in the animals with ATN in this study. In
ischemic as well as various etiologies of ATN, glomerular
0.37
0.32
0.27
0.22
0.17
0.12
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Table 3. Renal function and plasma concentrations of calciurn, phosphorus, and blood gases seven days after ischemic injury of kidneys
Ccr
Body Wt SCr mi/mini Pc Pc** P, pCO2
g mgidl 100 g mg/dl mg/dl mg/dl pH mm Hg
Sham 199 0.49 0.56 10.50 4.70 7.87 7.42 36.7
Controls ±5.5 ±0.01 ±0.02 ±0.11 ±0.05 ±0.16 ±0.02 ±2.5N= 7
ATN 198 0.48 0.56 10.39 4.73 7.54 7.45 35.2N = 8 ±3.5 ±0.01 ±0.01 ±0.12 ±0.08 ±0.27 ±0.02 ±1.1
P values NS NS NS NS NS NS NS NS
Abbrevi ations are in Table I.
Table 4. Production and metabolic clearance of calcitr
after ischemic injury of kidneys
jol seven days
Plasma
calcitriol MCR PR
pg/mi mi/mm/kg ng/kg/day
C.V.
%
Sham
Controls
N= 8
ATN
N = 7
115.8 0.26 42.1
±8.9 0.01 ±2.1
105.0 0.27 41.2
±4.9 ±0.01 ±2.6
4.9
± 1.08
6.7
±1.5
P values NS NS NS NS
Abbrev iations are in Table I.
filtration rates usually return to near normal values approxi-
mately seven days after the initial insult [4, 21], yet tubular
regeneration is often incomplete and lags behind recovery of
renal function [4, 211. The recovery of calcitriol synthesis on the
seventh day after ischemic tubular necrosis, therefore, suggests
that normal production of calcitriol does not require fully
regenerated tubular cells. Alternatively, compensatory mecha-
nisms of calcitriol synthesis may also be involved in the
recovery phase of ATN. Calcitriol could be predominately
synthesized by the mildly injured and completely recovered
tubular cells. A compensatory mechanism of calcitriol synthesis
occurs in acute unilaterally nephrectomized rats [221. Plasma
concentrations of calcitriol remain within normal values in rats
48 hours after unilateral nephrectomy. Parathyroid hormone,
which may be elevated after nephrectomy, does not appear to
be the factor maintaining the normal levels of calcitriol [22]. On
the other hand, plasma concentrations of calcitriol are greater
than normal values during recovery phase in rhabdomyolysis-
induced acute renal failure [10]. The elevated levels correlate
positively with the PTH concentrations.
In the present study, the MCR of calcitriol of animals with
ATN was not decreased, suggesting that the degradation of
E
0
3-Day control 3-Day ATN Means
0.37 T
0.32
0.27
0.22
• •______•
LD
0.37
0.32
0.27
0.22
9::=
0.17 0.17
0.12
18 19 20
0.12
18 19 19 20
Time, hours
Fig. 1. Individual and mean metabolic
clearance rats of caicitriol (MCR) at 18, 19,
and 20 hours after infusion of radiolabeiled
calcitriol in rats 3 days after ischemic injury
of kidneys. Symbols are in Means: open,
control; closed, ATN.
0.37
. 0.32
0.27
E 0.22
0.17
0.12
7-Day control
18 19 20
0.37
0.32
0.27
0.22
0.17
0.12
7-Day ATN
a__ •—
18 19 20
Time, hours
0.37
0.32
0.27
0.22
0.17
0.12
Means
18 19 20
Fig. 2. Individual and mean metabolic
clearance rates of calcitriol (MCR) at 18, 19
and 20 hours after infusion of radiolabelied
caicitriol in rats 7 days after ischemic injury
of kidneys. Symbols are in Means: ()
control; (•) ATN.
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Table 5. Plasma concentrations of creatinine, calcium, phosphorus,
and blood gases in animals with urine reinfusion for 24 hours
Controls
Body
wt Scr
g mg/dl
245 0.4k
PCa
mg/dl
10.0
Ca
mgldl
4.93
mg/di
7.04
pH
7.38
pCO2
mm
Hg
37.2
N = 8 ±11.4 ±0.01 ±0.20 ±0.03 ±0.17 ±0.01 ±1.1
Urine 250 2.17 8.78 4.87 12.0 7.15 33.4
Reinfusion ±10.2 ±0.08 ±0.18 ±0.04 ±0.91 ±0.03 ±1.6
N= 8
P values NS <0.001 <0.001 NS <0.001 <0.001 NS
Abbreviat ions are in Table I.
calcitriol is not altered in mild acute renal failure. Although loss
of the degradation enzyme, 24-hydroxylase, may occur in
necrotic kidney, the kidney is not considered a major organ of
calcitriol catabolism [23]. The loss of renal 24-hydroxylase
apparently did not affect the metabolic degradation of calcitriol
in ATN rats. We have demonstrated that unilaterally nephrec-
tomized animals with a comparable degree of renal failure for
three weeks had a significantly lower MCR of calcitriol com-
pared to sham controls [31. Thus metabolic degradation of
calcitj-iol could be decreased if the mild acute renal failure is
prolonged.
The production of calcitriol was significantly reduced in the
rats with uremia and normal kidney tissue. The animals devel-
oped severe uremia, acidosis and hyperphosphatemia. Both
metabolic acidosis [17—19] and hyperphosphatemia [20] have
been shown to suppress calcitriol synthesis. It is not clear
whether uremic serum also suppresses la-hydroxylase. Since
the decreased production was associated with a concomitant
reduction of metabolic degradation of calcitriol, the plasma
concentrations of calcitriol remained within normal values in
these animals. The reasons for decreased MCR of calcitriol in
these animals are not clear. Acute metabolic acidosis has been
shown to increase rather than decrease the MCR of calcitriol
[17]. Phosphate is known to regulate metabolic production, but
not metabolic clearance of calcitriol [6, 24]. Increased dietary
intake of phosphate does not appear to alter the MCR of
calcitriol in human subjects, although marked elevation of
plasma concentrations of phosphate did not occur in these
subjects [61.
Available evidence indicates that calcitriol-stimulated intes-
tinal calcium transport is lower in acute severe uremia produced
by bilateral nephrectomy [25]. This finding suggests that
Table 6. The effect of uremia on calcitriol metabolism in urine
reinfused rats
Plasma
calcitriol
pg/mi
MCR
mi/mm/kg
PR
ng/kg/day
C.V.
%
Control
N = 7
Urine
Reinfusion
N= 8
54.8
±7.0
48.8
±6.3
0.26
±0.01
0.17
±0.01
20.5
±2.9
9.42
±1.21
5.3
±0.9
6.4
±1.1
P values NS <0.001 <0.001 NS
Abbreviati ons are in Tab Ic 2.
endorgan resistance to calcitriol may develop in severe uremic
conditions. In the intestine calcitriol receptors mediate intesti-
nal calcium transport [26]. The endorgan resistance to calcitnol
could result from decreased calcitriol receptor sites or de-
creased calcitriol binding affinity by receptors in the intestine.
The MCR of calcitriol of rats with urine reinfusion was signif-
icantly decreased in comparison to control animals. Since MCR
of calcitriol occurs to a large extent in the intestine [27] and
perhaps in the liver and bone as well [23], the decreased
metabolic degradation of calcitriol could account for the lower
response of calcitriol-stimulated intestinal transport of calcium
in uremic rats 24 hours after bilateral nephrectomy [25].
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